Logo Logo Logo Logo Logo
  • About
    • About AIGHD
    • History
    • People
    • Partners
    • Fellows
    • Where we work
    • Annual Report
    • Careers
    • Contact
  • Research
    • Research Priorities
    • Joep Lange Chair & Fellows Program
    • Scientific Publications & PhD Theses
    • Research Briefs, Articles & Reports
  • Education
    • Bachelor
    • Masters
    • PhD
    • PhD Defenses
    • Internships
    • Student Testimonials
  • Policy
    • TB Vaccine Roadmap
  • Projects
  • News & Events
    • News
    • Events Calendar
    • INTEREST (HIV) Conference
    • Global Health Symposia
    • Inaugural Lectures
  • About

    • About AIGHD
    • History
    • People
    • Partners
    • Fellows
    • Where we work
    • Annual Report
    • Careers
    • Contact
  • Research

    • Research Priorities
    • Joep Lange Chair & Fellows Program
    • Scientific Publications & PhD Theses
    • Research Briefs, Articles & Reports
  • Education

    • Bachelor
    • Masters
    • PhD
    • PhD Defenses
    • Internships
    • Student Testimonials
  • Policy
    • TB Vaccine Roadmap
  • Projects
  • News & Events

    • News
    • Events Calendar
    • INTEREST (HIV) Conference
    • Global Health Symposia
    • Inaugural Lectures

03 Sep High positive predictive value of Xpert in a low rifampicin resistance prevalence setting.

Posted at 00:00h in by AIGHD

Authored by: Trajman A, Durovni B, Saraceni V, Cordeiro-Santos M, Cobelens F., van den Hof S.
In: European Respiratory Journal, 2014
http://www.ncbi.nlm.nih.gov/pubmed/?term=High+positive+predictive+value+of+Xpert+in+a+low+rifampicin+resistance+prevalence+setting
http://erj.ersjournals.com/content/early/2014/09/03/09031936.00115514.long



logo
Contact
AHTC, Tower C4
Paasheuvelweg 25
1105 BP Amsterdam
Netherlands
Email: info@aighd.org
Phone: +31 20 210 3960
Twitter
Tweets by @aighd
QUICK LINKS

Annual Report
INTEREST (HIV) Conference
Vacancies
ANBI
Privacy Statement
Cookie Policy
Portal

© Copyright 2017 Amsterdam Institute for Global Health & Development. All rights reserved.